Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine

Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity

(2011) Kenta Moriwaki et al.   CANCER SCIENCE

Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma

(2011) Po Zhao et al.   CANCER SCIENCE

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Interferon-α counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer

(2009) Luca Persano et al.   CARCINOGENESIS

Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer

(2009) Maria–Theresa Mueller et al.   GASTROENTEROLOGY

IFNα activates dormant haematopoietic stem cells in vivo

(2009) Marieke A. G. Essers et al.   NATURE

Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses

(2009) S. Joshi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating Cells

(2008) Naotsugu Haraguchi et al.   ANNALS OF SURGICAL ONCOLOGY

In vitro and in vivo effect of IFNα on B16F10 melanoma in two models: Subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice)

(2008) Cristina Martínez Conesa et al.   BIOMEDICINE & PHARMACOTHERAPY

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

(2008) S Maeda et al.   BRITISH JOURNAL OF CANCER

The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN-  Antitumor Effects

(2008) L. Moserle et al.   CANCER RESEARCH

Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis

(2008) Christine E. Eyler et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression of CD133-1 and CD133-2 in ovarian cancer

(2007) G. FERRANDINA et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER